Skip to main content Accessibility help
×
Hostname: page-component-848d4c4894-75dct Total loading time: 0 Render date: 2024-05-01T13:18:47.922Z Has data issue: false hasContentIssue false

10 - Medication Safety in Special Contexts

Published online by Cambridge University Press:  09 April 2021

Alan Merry
Affiliation:
University of Auckland
Joyce Wahr
Affiliation:
University of Minnesota
Get access

Summary

In previous chapters, we have discussed medication safety in perioperative settings: for the most part, we have used literature and data from high-income countries (HICs) and have focused primarily on broad categories of the medication process (transitions of care, intraoperative, postoperative, etc.) to differentiate risks in each location. In this chapter, we turn our attention to some special contexts where medication safety has unique aspects. First, we review data from low- and middle-income countries (LMIC), as their special circumstances open them to different medication risks and significantly limit which of the recommendations we have made can be implemented. Both of the authors have traveled to a variety of LMIC, and we have been deeply impressed with the expertise, dedication, and resourcefulness of healthcare workers who often have to work under very difficult conditions with very limited resources. Information is usually accessible, in large part due to the penetration of the Internet into nearly all countries, which provides online access to current literature, books, and web-based guidelines that is not limited by borders, although it may be by economic considerations. However, in many countries, particularly in Sub-Saharan Africa, there is a dearth of trained physicians in general, and trained anesthesiologists in particular (1). Many anesthetics are administered by nurses or technicians with variable levels of training in anesthesia. Often these anesthesia providers earn poor salaries, have poor working conditions, and are not in a strong position to exercise influence on behalf of themselves or their patients. There may also be shortages of nursing staff trained to care for postoperative patients, and in some places, the burden of this care may fall heavily on families, who, of course, seldom have any relevant training.

Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2021

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Kempthorne, P, Morriss, WW, Mellin-Olsen, J, Gore-Booth, J. The WFSA Global Anesthesia Workforce Survey. Anesth Analg. 2017;125(3):981990.CrossRefGoogle ScholarPubMed
WFSA Board and Council. WFSA Position Statement on Anaesthesiology and Universal Health Coverage. Update in Anaesthesia. 2017;32:6.Google Scholar
Meara, JG, Leather, AJM, Hagander, L, et al. Global Surgery 2030: evidence and solutions for achieving health, welfare, and economic development. Lancet. 2015;386(9993):569624.Google Scholar
Mills, A. Health care systems in low- and middle-income countries. N Engl J Med. 2014;370(6):552557.Google Scholar
Bennett, S, Agyepong, IA, Sheikh, K, et al.. Building the field of health policy and systems research: an agenda for action. PLoS Med. 2011;8(8):e1001081.CrossRefGoogle ScholarPubMed
Gilson, L, Hanson, K, Sheikh, K, et al.. Building the field of health policy and systems research: social science matters. PLoS Med. 2011;8(8):e1001079.CrossRefGoogle ScholarPubMed
Sheikh, K, Gilson, L, Agyepong, IA, et al.. Building the field of health policy and systems research: framing the questions. PLoS Med. 2011;8(8):e1001073.Google Scholar
Khan, FA, Merry, AF. Improving anesthesia safety in low-resource settings. Anesth Analg. 2018;126(4):13121320.Google Scholar
Weiser, TG, Haynes, AB, Molina, G, et al. Estimate of the global volume of surgery in 2012: an assessment supporting improved health outcomes. Lancet. 2015;385(suppl 2):S11.Google Scholar
Director-General. Universal Health Coverage: Preparation for the High-Level Meeting of the United Nations General Assembly on Universal Health Coverage. A Report by the Director-General. Geneva: World Health Organization; 2018. Accessed January 3, 2020. https://apps.who.int/gb/ebwha/pdf_files/EB144/B144_14-en.pdfGoogle Scholar
Meara, JG, Greenberg, SL. The Lancet Commission on Global Surgery Global surgery 2030: evidence and solutions for achieving health, welfare and economic development. Surgery. 2015;157(5):834835.Google Scholar
Weiser, TG, Regenbogen, SE, Thompson, KD, et al. An estimation of the global volume of surgery: a modelling strategy based on available data. Lancet. 2008;372(9633):139144.Google Scholar
Daniels, KM, Riesel, JN, Meara, JG. The scale-up of the surgical workforce. Lancet. 2015;385(suppl 2):S41.Google Scholar
Hanf, M, Van-Melle, A, Fraisse, F, et al. Corruption kills: estimating the global impact of corruption on children deaths. PLoS One. 2011;6(11):e26990.CrossRefGoogle ScholarPubMed
Franz, S, Zeh, A, Schablon, A, Kuhnert, S, Nienhaus, A. Aggression and violence against health care workers in Germany – a cross sectional retrospective survey. BMC Health Serv Res. 2010;10:51.Google Scholar
Kowalczuk, K, Krajewska-Kulak, E. Patient aggression towards different professional groups of healthcare workers. Ann Agric Environ Med. 2017;24(1):113116.Google Scholar
Ri, S, Blair, AH, Kim, CJ, Haar, RJ. Attacks on healthcare facilities as an indicator of violence against civilians in Syria: an exploratory analysis of open-source data. PLoS One. 2019;14(6):e0217905.CrossRefGoogle ScholarPubMed
Schinirring, L. WHO Ebola responder killed in hospital attack. CIDRAP News. April 19, 2019. Accessed January 3, 2020. https://www.cidrap.umn.edu/news-perspective/2019/04/who-ebola-responder-killed-hospital-attackGoogle Scholar
Sheikh, A, Dhingra-Kumar, N, Kelley, E, Kieny, MP, Donaldson, LJ. The third global patient safety challenge: tackling medication-related harm. Bull World Health Organ. 2017;95(8):546-A.Google Scholar
Donaldson, LJ, Kelley, ET, Dhingra-Kumar, N, Kieny, MP, Sheikh, A. Medication without harm: WHO’s third global patient safety challenge. Lancet. 2017;389(10080):16801681.Google Scholar
World Health Organization. WHO Global Patient Safety Challenge: Medication Without Harm. Geneva: World Health Organization; 2017. Accessed January 3, 2020. https://www.who.int/patientsafety/medication-safety/medication-without-harm-brochure/en/Google Scholar
World Health Organization, Regional Office for South-East Asia. Equitable Access to Medicines for Universal Health Coverage by 2030. Geneva: World Health Organization, Regional Office for South-East Asia; 2017. Accessed January 17, 2020. https://www.who.int/iris/handle/10665/258914Google Scholar
Anonymous. Woman says her son couldn't afford his insulin – now he's dead. CBS This Morning. January 4, 2019. Accessed December 26, 2019. https://www.cbsnews.com/news/mother-fights-for-lower-insulin-prices-after-sons-tragic-death/Google Scholar
Anonymous. What drove the 300% rise in insulin prices (and how to reverse it). Advisory Board. The Daily Briefing. November 7, 2018. Accessed December 26, 2019. https://www.advisory.com/daily-briefing/2018/11/07/insulin-pricesGoogle Scholar
Federal Trade Commission Staff. Pay-For-Delay: How Drug Company Pay-Offs Cost Consumers Billions: A Federal Trade Commission Staff Study. Washington, DC: Federal Trade Commission; 2010. Accessed January 3, 2020. https://www.ftc.gov/reports/pay-delay-how-drug-company-pay-offs-cost-consumers-billions-federal-trade-commission-staffGoogle Scholar
Frye, JE. International Drug Price Indicator Guide. Cambridge, MA: Management Sciences for Health; 2010.Google Scholar
Kesselheim, AS, Avorn, J, Sarpatwari, A. The high cost of prescription drugs in the United States: origins and prospects for reform. JAMA. 2016;316(8):858871.CrossRefGoogle ScholarPubMed
Leisinger, KM, Garabedian, LF, Wagner, AK. Improving access to medicines in low and middle income countries: corporate responsibilities in context. South Med Rev. 2012;5(2):38.Google Scholar
Stevens, H, Huys, I. Innovative approaches to increase access to medicines in developing countries. Front Med. 2017;4:Article 218.Google Scholar
World Health Organization. Development of the Roadmap on Access to Medicines and Vaccines 2019–2023. Geneva: World Health Organization; 2019. Accessed January 20, 2020. https://www.who.int/medicines/access_use/road-map-medicines-vaccines/en/Google Scholar
Director-General. Medicines, Vaccines and Health Products: Access to Medicines and Vaccines. Geneva: World Health Organization; 2018. Accessed January 3, 2020. https://apps.who.int/gb/ebwha/pdf_files/EB144/B144_18-en.pdfGoogle Scholar
Araujo, AM, Valente, MJ, Carvalho, M, et al. Raising awareness of new psychoactive substances: chemical analysis and in vitro toxicity screening of “legal high” packages containing synthetic cathinones. Arch Toxicol. 2015;89(5):757771.Google Scholar
Akhgari, M, Moradi, FMS, Ziarati, P. The texture of psychoactive illicit drugs in Iran: adulteration with lead and other active pharmaceutical ingredients. J Psychoactive Drugs. 2018;50(5):451459.Google Scholar
Miliano, C, Margiani, G, Fattore, L, De Luca, MA. Sales and advertising channels of New Psychoactive Substances (NPS): internet, social networks, and smartphone apps. Brain Sci. 2018;8(7):29.Google Scholar
Liao, Y, Tang, YL, Hao, W. Ketamine and international regulations. Am J Drug Alcohol Abuse. 2017;43(5):495504.Google Scholar
Wadsworth, E, Drummond, C, Deluca, P. The dynamic environment of crypto markets: the lifespan of new psychoactive substances (NPS) and vendors selling NPS. Brain Sci. 2018;8(3):46. Accessed July 18, 2020. https://www.mdpi.com/2076-3425/8/3/46Google Scholar
United Nations. Convention on Psychotropic Substances. New York, NY: United Nations; 1971. Accessed January 20, 2020. https://www.incb.org/documents/Psychotropics/conventions/convention_1971_en.pdfGoogle Scholar
Hamilton, WL, Doyle, C, Halliwell-Ewen, M, Lambert, G. Public health interventions to protect against falsified medicines: a systematic review of international, national and local policies. Health Policy Plan. 2016;31(10):14481466.Google Scholar
Institute of Medicine. Countering the Problem of Falsified and Substandard Drugs. Washington, DC: National Academies Press; 2013.Google Scholar
Blackstone, EA, Fuhr, JP Jr, Pociask, S. The health and economic effects of counterfeit drugs. Am Health Drug Benefits. 2014;7(4):216224.Google Scholar
World Health Organization. A Study on the Public Health and Socioeconomic Impact of Substandard and Falsified Medical Products. Geneva: World Health Organization; 2017. Accessed January 18, 2020. https://www.who.int/medicines/regulation/ssffc/publications/se-study-sf/en/Google Scholar
Ozawa, S, Evans, DR, Bessias, S, et al. Prevalence and estimated economic burden of substandard and falsified medicines in low- and middle-income countries: a systematic review and meta-analysis. JAMA Netw Open. 2018;1(4):e181662.Google Scholar
Mumphansha, H, Nickerson, JW, Attaran, A, et al. An analysis of substandard propofol detected in use in Zambian anesthesia. Anesth Analg. 2017;125(2):616619.CrossRefGoogle ScholarPubMed
Renschler, JP, Walters, KM, Newton, PN, Laxminarayan, R. Estimated under-five deaths associated with poor-quality antimalarials in sub-Saharan Africa. Am J Trop Med Hyg. 2015;92(6 suppl):119126.CrossRefGoogle ScholarPubMed
Mackey, TK, Cuomo, R, Guerra, C, Liang, BA. After counterfeit Avastin – what have we learned and what can be done? Nat Rev Clin Oncol. 2015;12(5):302308.CrossRefGoogle Scholar
Anonymous. Combating counterfeit drugs. Lancet. 2008;371(9624):1551.Google Scholar
Chess, EK, Bairstow, S, Donovan, S, et al. Case study: contamination of heparin with oversulfated chondroitin sulfate. Handb Exp Pharmacol. 2012(207):99125.Google Scholar
Nayyar, GML, Breman, JG, Herrington, JE. The global pandemic of falsified medicines: laboratory and field innovations and policy perspectives. Am J Trop Med Hyg. 2015;92(6 suppl):27.Google Scholar
Binagwaho, A, Bate, R, Gasana, M, et al. Combatting substandard and falsified medicines: a view from Rwanda. PLoS Med. 2013;10(7):e1001476.Google Scholar
Kovacs, S, Hawes, SE, Maley, SN, et al. Technologies for detecting falsified and substandard drugs in low and middle-income countries. PLoS One. 2014;9(3):e90601.Google Scholar
Batson, JS, Bempong, DK, Lukulay, PH, et al. Assessment of the effectiveness of the CD3+ tool to detect counterfeit and substandard anti-malarials. Malar J. 2016;15(1):119.CrossRefGoogle ScholarPubMed
Platek, SF, Ranieri, N, Batson, J. Applications of the FDA’s Counterfeit Detection Device (CD3+) to the examination of suspect counterfeit pharmaceutical tablets and packaging. Microsc Microanal. 2016; 22(suppl 3). Accessed July 26, 2019. https://www.cambridge.org/core/services/aop-cambridge-core/content/view/B527A009E3E4D4C248E53C0BD49AEEAB/S1431927616006206a.pdf/div-class-title-applications-of-the-fda-s-counterfeit-detection-device-cd3-to-the-examination-of-suspect-counterfeit-pharmaceutical-tablets-and-packaging-div.pdfGoogle Scholar
Shuker, C, Bohm, G, Bramley, D, et al. The Health Quality and Safety Commission: making good health care better. N Z Med J. 2015;128(1408):97109.Google Scholar
Yusefzadeh, H, Didarloo, A, Nabilou, B. Provider knowledge and performance in medication injection safety in anesthesia: a mixed method prospective crosses sectional study. PLoS One. 2018;13(12):e0207572.Google Scholar
World Health Organization. WHO Best Practices for Injections and Related Procedures Toolkit. Geneva: World Health Organization; 2010. Accessed January 18, 2020. https://www.who.int/infection-prevention/publications/best-practices_toolkit/en/Google Scholar
Decamp, M, Joffe, S, Fernandez, CV, Faden, RR, Unguru, Y. Chemotherapy drug shortages in pediatric oncology: a consensus statement. Pediatrics. 2014;133(3):e716e724.Google Scholar
Fox, ER, Sweet, BV, Jensen, V. Drug shortages: a complex health care crisis. Mayo Clin Proc. 2014;89(3):361373.Google Scholar
Jensen, V, Kimzey, LM, Goldberger, MJ. FDA’s role in responding to drug shortages. Am J Health Syst Pharm. 2002;59(15):14231425.Google Scholar
ASHP Expert Panel on Drug Product Shortages; Fox, ER, Birt, A, James, KB, et al. ASHP guidelines on managing drug product shortages in hospitals and health systems. Am J Health Syst Pharm. 2009;66(15):13991406.Google Scholar
Vail, E, Gershengorn, HB, Hua, M, et al. Association between US norepinephrine shortage and mortality among patients with septic shock. JAMA. 2017;317(14):14331442.Google Scholar
Jagsi, R, Spence, R, Rathmell, WK, et al. Ethical considerations for the clinical oncologist in an era of oncology drug shortages. Oncologist. 2014;19(2):186192.Google Scholar
Romito, B, Stone, J, Ning, N, et al. How drug shortages affect clinical care: the case of the surgical anesthetic propofol. Hosp Pharm. 2015;50(9):798805.CrossRefGoogle ScholarPubMed
Thompson, K, Alred, J, Deyo, A, Sievert, AN, Sistino, JJ. Effect of new heparin potency on activated clotting time during pediatric cardiac surgery: a retrospective chart review. J Extra Corpor Technol. 2014;46(3):224228.CrossRefGoogle ScholarPubMed
Davies, BJ, Hwang, TJ, Kesselheim, AS. Ensuring access to injectable generic drugs – the case of intravesical BCG for bladder cancer. N Engl J Med. 2017;376(15):14011403.CrossRefGoogle ScholarPubMed
Hernandez, I, Sampathkumar, S, Good, CB, Kesselheim, AS, Shrank, WH. Changes in drug pricing after drug shortages in the United States. Ann Intern Med. 2019;170(1):7476.CrossRefGoogle ScholarPubMed
Iacobucci, G. Drug shortages cost NHS £38m in November. BMJ. 2017;359:j5883.Google Scholar
Smetzer, J, Baker, C, Byrne, FD, Cohen, MR. Shaping systems for better behavioral choices: lessons learned from a fatal medication error. Jt Comm J Qual Patient Saf. 2010;36(4):152163.Google Scholar
Doring, M, Brenner, B, Handgretinger, R, Hofbeck, M, Kerst, G. Inadvertent intravenous administration of maternal breast milk in a six-week-old infant: a case report and review of the literature. BMC Res Notes. 2014;7:17.Google Scholar
Simmons, D, Phillips, MS, Grissinger, M, Becker, SC; USP Safe Medication Use Expert Committee. Error-avoidance recommendations for tubing misconnections when using Luer-tip connectors: a statement by the USP Safe Medication Use Expert Committee. Jt Comm J Qual Patient Saf. 2008;34(5):293296, 245.Google Scholar
Khan, EI, Khadijah, I. Intravenous bupivacaine infusion: an error in adminstration – a case report. Middle East J Anaesthesiol. 2008;19(6):13971400.Google Scholar
Hicks, RW, Becker, SC. An overview of intravenous-related medication administration errors as reported to MEDMARX, a national medication error-reporting program. J Infus Nurs. 2006;29(1):2027.Google Scholar
The Joint Commission. Avoiding catheter and tubing mis-connections. Patient Safety Solutions, volume 1, solution 7. 2007. Accessed July 19, 2020. www.who.int/patientsafety/solutions/patientsafety/PS-Solution7.pdf?ua=1Google Scholar
Slyter, H, Liwnicz, B, Herrick, MK, Mason, R. Fatal myeloencephalopathy caused by intrathecal vincristine. Neurology. 1980;30(8):867871.Google Scholar
Reason, J. Beyond the organisational accident: the need for “error wisdom” on the frontline. Qual Saf Health Care. 2004;13(suppl 2):ii2833.Google Scholar
Berwick, DM. Not again! BMJ. 2001;322(7281):247248.Google Scholar
Noble, DJ, Donaldson, LJ. The quest to eliminate intrathecal vincristine errors: a 40-year journey. Qual Saf Health Care. 2010;19(4):323326.Google Scholar
Merry, AF, Brookbanks, W. Merry and McCall Smith’s Errors, Medicine and the Law. 2nd Edition. Cambridge: Cambridge University Press; 2017.Google Scholar
Gilbar, P, Chambers, CR, Larizza, M. Medication safety and the administration of intravenous vincristine: international survey of oncology pharmacists. J Oncol Pharm Pract. 2015;21(1):1018.Google Scholar
Reddy, GK, Brown, B, Nanda, A. Fatal consequences of a simple mistake: how can a patient be saved from inadvertent intrathecal vincristine? Clin Neurol Neurosurg. 2011;113(1):6871.CrossRefGoogle ScholarPubMed
Ayani, N, Sakuma, M, Morimoto, T, et al. The epidemiology of adverse drug events and medication errors among psychiatric inpatients in Japan: the JADE study. BMC Psychiatry. 2016;16:303.Google Scholar
Mitchell, AJ, Delaffon, V, Vancampfort, D, Correll, CU, De Hert, M. Guideline concordant monitoring of metabolic risk in people treated with antipsychotic medication: systematic review and meta-analysis of screening practices. Psychol Med. 2012;42(1):125147.Google Scholar
Rummel-Kluge, C, Komossa, K, Schwarz, S, et al. Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: a systematic review and meta-analysis. Schizophr Res. 2010;123(2–3):225233.Google Scholar
Lee, J, Dalack, GW, Casher, MI, Eappen, SA, Bostwick, JR. Persistence of metabolic monitoring for psychiatry inpatients treated with second-generation antipsychotics utilizing a computer-based intervention. J Clin Pharm Ther. 2016;41(2):209213.Google Scholar
Soerensen, AL, Lisby, M, Nielsen, LP, Poulsen, BK, Mainz, J. The medication process in a psychiatric hospital: are errors a potential threat to patient safety? Risk Manag Healthc Policy. 2013;6:2331.Google Scholar
Prins, MC, Drenth-van Maanen, AC, Kok, RM, Jansen, PA. Use of a structured medication history to establish medication use at admission to an old age psychiatric clinic: a prospective observational study. CNS Drugs. 2013;27(11):963969.Google Scholar
Keers, RN, Williams, SD, Vattakatuchery, JJ, et al. Medication safety at the interface: evaluating risks associated with discharge prescriptions from mental health hospitals. J Clin Pharm Ther. 2015;40(6):645654.Google Scholar
Fazio, G, Vernuccio, F, Grutta, G, Re, GL. Drugs to be avoided in patients with long QT syndrome: focus on the anaesthesiological management. World J Cardiol. 2013;5(4):8793.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×